Adjuvant Platform Technology
Adjuvant is a substance used in combination with an antigen to enhance the in vivo cellular and humoral immune response to a particular antigen.
Alum, which was developed over 70 years ago, is the most widely used immune enhancer used in commercial vaccines.
In recent years, many researches have been achieved on innate immunity, and an innate immunity enhancer is being used as an adjuvant.
Thus, the adjuvant can be used as a vaccine for various diseases by replacing only specific antigens, and we are working on applying them to various fields.
Developing Advanced Formulations for Adjuvant
Developing Next-generation Adjuvant
Cell Therapy Platform Technology
Present in the lymphatic system and intercellular spaces of various tissues, dendritic cells (DCs) are antigen presenting cells (APCs) having strong antigen-presenting abilities.
DCs may either stimulate or regulate immunity, depending on the differentiating environment.
Treatment using DC platform can minimize side effects because they are able to control antigen-specific immunity differently from conventional drugs.
In our company, we are in the process of applying a cell therapy agent to intractable diseases, based on the technology of modulating the function of DCs.
Terms & Conditions
Quratis / Tel : +82-2-866-0604 / Fax : +82-2-867-0125
/ Email : email@example.com
Copyright (c) 2017 Quratis. All rights reserved. Hosting by